Table 1.
Participants demographics for Dario users who completed vaccination status in surveys (2) or (3) (completers) and those who did not complete either of the 2 surveys (noncompleters).
|
|
Completers (n=8431) | Noncompleters (n=56,473) | P value | Effect size | |||||||
| Age (years), mean (SD) | 63.7 (11) | 56.6 (13.2) | <.001a | Cohen d=0.58 | |||||||
| Gender, n (%) | <.001b | Cramer V=0.03 | |||||||||
|
|
Female | 4376 (52.1) | 26728 (47.5) |
|
|
||||||
|
|
Male | 5022 (47.9) | 29508 (52.5) |
|
|
||||||
|
|
Other | 0 (0) | 5 (0) |
|
|
||||||
| BMI, mean (SD) | 33.2 (7.8) | 33.4 (8.4) | <.05a | Cohen d=0.02 | |||||||
| Year of diagnosis (duration of diabetes), mean (SD) | 2009.7 (50.7) | 2012.2 (50.8) | <.001a | Cohen d=0.05 | |||||||
| Diabetes type, n (%) | <.001b | Cramer V=0.06 | |||||||||
|
|
Type 1 | 453 (5.4) | 5955 (10.6) |
|
|
||||||
|
|
Type 2 | 7933 (94.1) | 50272 (89.1) |
|
|
||||||
|
|
Other | 32 (0.4) | 156 (0.3) |
|
|
||||||
| Insulin treatment, n (%) | <.001b | Cramer V=0.01 | |||||||||
|
|
No | 5730 (69.2) | 36583 (69.2) |
|
|
||||||
|
|
Pen | 2248 (27.6) | 14716 (27.8) |
|
|
||||||
|
|
Pump | 169 (2.1) | 1592 (3) |
|
|
||||||
| Comorbidities, n (%) | <.001b | Cramer V=0.13 | |||||||||
|
|
Cardio-metabolicc | 3930 (56.6) | 25211 (59) |
|
|
||||||
|
|
MSKd | 587 (8.5) | 1487 (3.5) |
|
|
||||||
|
|
BHe | 458 (6.6) | 6583 (15.4) |
|
|
||||||
|
|
None | 1966 (28.3) | 9443 (22.1) |
|
|
||||||
aTwo sample t test for comparing mean samples.
bChi-square test of independence.
cCardio-metabolic (cardiovascular, cerebrovascular, endocrine, high blood lipids, hypertension, kidney disease, obesity, and vascular).
dMSK: musculoskeletal.
eBH: behavioral health.